View clinical trials related to Von Hippel-Lindau Disease.
Filter by:This open-label Phase 1 study will evaluate the efficacy and safety of BPI-452080 in patients with Solid Tumors
The Relaxation Response Resiliency Program (3RP) has shown efficacy in improving coping and resilience across diverse populations; however, little is known about how it helps individuals manage the challenges of living with a chronic illness. This study proposes to pilot test an adapted version of the 3RP among patients living with VHL.